The faculty will highlight the latest updates on clinical trials for paroxysmal nocturnal hemoglobinuria (PNH) and provide their practical clinical insights to enhance the implementation of these trials into practice. These experts will discuss new agents, explore how patient management is approached today, and what treatment may look like in the near future.